Hongbin Liu
- Microbiology top 5%
- Antimicrobial Peptides and Activities 5
- Biological Psychiatry top 10%
- Food Science top 2%
- Probiotics and Fermented Foods 7
- Animal Science and Zoology top 5%
- Molecular Biology top 10%
- Gut microbiota and health 16
- Inflammasome and immune disorders 3
-
- Clostridium difficile and Clostridium perfringens research 7
-
- Infant Nutrition and Health 3
-
- Inflammatory Bowel Disease 3
-
- Immune cells in cancer 3
Hongbin Liu
44 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 124
- Microbiology 159
- Biological Psychiatry 60
- Food Science 374
- Animal Science and Zoology 176
- Molecular Biology 1.1k
Countries citing papers authored by Hongbin Liu
This map shows the geographic impact of Hongbin Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongbin Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongbin Liu more than expected).
Fields of papers citing papers by Hongbin Liu
This network shows the impact of papers produced by Hongbin Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongbin Liu. The network helps show where Hongbin Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hongbin Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Selective utilization of medicinal polysaccharides by human gut Bacteroides and Parabacteroides speciesbreakdown → | 2025 | 25 |
| 2 | 2025 | 3 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 6 | |
| 5 | 2024 | 12 | |
| 6 | 2023 | 5 | |
| 7 | 2023 | 4 | |
| 8 | 2022 | 83 | |
| 9 | 2022 | 38 | |
| 10 | 2022 | 7 | |
| 11 | 2021 | 43 | |
| 12 | 2021 | 22 | |
| 13 | 2020 | 7 | |
| 14 | 2019 | 215 | |
| 15 | 2019 | 70 | |
| 16 | 2018 | 35 | |
| 17 | 2018 | 75 | |
| 18 | 2016 | 73 | |
| 19 | 2015 | 8 | |
| 20 | 2014 | 27 |
About Hongbin Liu
Hongbin Liu is a scholar working on Microbiology, Molecular Biology and Biological Psychiatry, having authored 45 papers that have together received 1.8k indexed citations. Recurring topics across this work include Gut microbiota and health (16 papers), Probiotics and Fermented Foods (7 papers), Clostridium difficile and Clostridium perfringens research (7 papers), Antimicrobial Peptides and Activities (5 papers), Infant Nutrition and Health (3 papers), Inflammasome and immune disorders (3 papers), Inflammatory Bowel Disease (3 papers) and Immune cells in cancer (3 papers). The work is most often cited by research in Microbiology (159 citations), Biological Psychiatry (60 citations) and Food Science (374 citations). Hongbin Liu has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Shiyan Qiao, Xiangfang Zeng, Haitao Yu, Xiaoya Zhang, Michael A. Brown, Jianfei Zhao, Guolong Zhang, Lijun Shang, Yuming Wang and Shuang Cai. Their work appears in journals such as Nature Communications, PLoS ONE and Journal of Agricultural and Food Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.